Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction

Abstract Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐b...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoko Inoue, Keiji Matsunaga, Waki Kobayashi, Tetsuo Minamino
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical Case Reports
Subjects:
acute decompensated heart failure
cancer therapy‐related cardiac dysfunction
inappropriate tachycardia
ivabradine
up‐titration
β‐Blocker
Online Access:https://doi.org/10.1002/ccr3.6890
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐blockers usage for treating patients with acute decompensated HFrEF.
ISSN:2050-0904

Similar Items